Metabolic and mitochondrial myopathies
- 1 November 1999
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Rheumatology
- Vol. 11 (6) , 462-467
- https://doi.org/10.1097/00002281-199911000-00003
Abstract
Metabolic myopathies are the result of genetic defects that cause disordered energy metabolism. These diseases can cause a variety of myopathic syndromes and can become clinically manifest at any age. Recent advances in the understanding of the molecular and metabolic bases for these diseases have resulted in expanded clinical descriptions, recognition of additional entities, and development of new therapeutic approaches.Keywords
This publication has 32 references indexed in Scilit:
- Immunoglobulin therapy in inflammatory myopathiesJournal of Neurology, Neurosurgery & Psychiatry, 1998
- Various types of herediary inclusion body myopathies map to chromosome 9p1‐q1Annals of Neurology, 1997
- Inclusion body myositis: Clinical and pathological boundariesAnnals of Neurology, 1996
- Hereditary Inclusion Body Myopathy Maps to Chromosome 9p1-q1Human Molecular Genetics, 1996
- High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments.Journal of Clinical Investigation, 1994
- β‐Amyloid precursor epitopes in muscle fibers of inclusion body myositisAnnals of Neurology, 1993
- β-amyloid protein immunoreactivity in muscle of patients with inclusion-body myositisThe Lancet, 1992
- Leukocytapheresis in inclusion body myositisJournal of Clinical Apheresis, 1987
- Inclusion body myositis: a case with associated collagen vascular disease responding to treatment.Journal of Neurology, Neurosurgery & Psychiatry, 1985
- Myxovirus-Like Structures in a Case of Human Chronic PolymyositisScience, 1967